版本:
中国

BRIEF-uniQure receives EMA agency priority medicines (PRIME) designation for AMT-060

April 25 Uniqure Nv:

* uniQure receives European Medicines Agency priority medicines (PRIME) designation for AMT-060 in Hemophilia B Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐